Ondine Biomedical Inc (OBI) - Total Liabilities

Latest as of December 2025: GBX10.91 Million GBX ≈ $1.33K USD

Based on the latest financial reports, Ondine Biomedical Inc (OBI) has total liabilities worth GBX10.91 Million GBX (≈ $1.33K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Ondine Biomedical Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.

Ondine Biomedical Inc - Total Liabilities Trend (2001–2025)

This chart illustrates how Ondine Biomedical Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Ondine Biomedical Inc total assets.

Ondine Biomedical Inc Competitors by Total Liabilities

The table below lists competitors of Ondine Biomedical Inc ranked by their total liabilities.

Company	Country	Total Liabilities
OPTIMI HEALTH CORP. F:8BN	Germany	€9.97 Million
Tinybuild Inc LSE:TBLD	UK	GBX11.51 Million
Kodal Minerals PLC LSE:KOD	UK	GBX417.79K
Contagious Gaming Inc V:CNS	Canada	CA$1.75 Million
Onward Opportunities Ltd LSE:ONWD	UK	GBX620.00K
CaNickel Mining Ltd V:CML	Canada	CA$132.62 Million
Microlise Group PLC LSE:SAAS	UK	GBX59.69 Million
Sunindo Adipersada Tbk Pt JK:TOYS	Indonesia	Rp109.24 Billion

Liability Composition Analysis (2001–2025)

This chart breaks down Ondine Biomedical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Ondine Biomedical Inc's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.23	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.13	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.76	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ondine Biomedical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ondine Biomedical Inc (2001–2025)

The table below shows the annual total liabilities of Ondine Biomedical Inc from 2001 to 2025.

Year	Total Liabilities	Change
2025-12-31	GBX10.91 Million ≈ $1.33K	+83.50%
2024-12-31	GBX5.95 Million ≈ $723.33	+62.92%
2023-12-31	GBX3.65 Million ≈ $443.98	-25.91%
2022-12-31	GBX4.92 Million ≈ $599.23	+9.86%
2021-12-31	GBX4.48 Million ≈ $545.45	-87.71%
2020-12-31	GBX36.46 Million ≈ $4.44K	+25.80%
2019-12-31	GBX28.99 Million ≈ $3.53K	+29.42%
2018-12-31	GBX22.40 Million ≈ $2.72K	+84.24%
2017-12-31	GBX12.16 Million ≈ $1.48K	+439.10%
2010-12-31	GBX2.25 Million ≈ $274.35	+68.11%
2009-12-31	GBX1.34 Million ≈ $163.19	-16.65%
2008-12-31	GBX1.61 Million ≈ $195.79	-25.50%
2007-12-31	GBX2.16 Million ≈ $262.81	+15.34%
2006-12-31	GBX1.87 Million ≈ $227.85	+151.16%
2005-12-31	GBX745.61K ≈ $90.72	+218.65%
2003-08-31	GBX233.99K ≈ $28.47	+62.35%
2002-08-31	GBX144.13K ≈ $17.54	+148.43%
2001-08-31	GBX58.02K ≈ $7.06	--

About Ondine Biomedical Inc

LSE:OBI UK Biotechnology

Market Cap

$679.55K

GBX5.59 Billion GBX

Market Cap Rank

#30907 Global

#873 in UK

Share Price

GBX10.75

Change (1 day)

+0.00%

52-Week Range

GBX8.00 - GBX15.40

All Time High

GBX58.50